Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Boothwyn Pharmacy LLC recalls Semaglutide

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Subpotent Drug
Products
  • Semaglutide
Where it was sold

U.S. Nationwide

Nationwide

Units affected
648 vials
About this recall
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy